Nowgen event: Personalised medicine study day
01 Nov 2011
One-day session on 8 December 2011 (Early Bird discount extended to 9 November).
Description
This one day course is being delivered in partnership with Dr William Newman from Central Manchester University Hospitals NHS Foundation Trust. The programme will focus in particular on the use of personalised medicine (pharmacogenetics) to improve the safety and effi cacy of drug treatment in various disease areas; it will also cover the health economic implications. This is an introductory level course that is suitable for delegates within the pharmaceutical industry and healthcare sector.
Overview
- Introduction to pharmacogenetics (Dr Bill Newman, Central Manchester Hospitals and University of Manchester)
- Ethical implications of personalised medicine (Dr Tara Clancy, Central Manchester Hospitals and University of Manchester)
- Pharmacogenetics in paediatric medicine (Professor Peter Clayton, Central Manchester Hospitals and University of Manchester)
- Genetics and adverse drug reactions (Dr Dann Carr, University of Liverpool)
- Variability in response to warfarin (Dr Andrea Jorgensen, University of Liverpool)
- Abacavir and HIV pharmacogenetics (Dr Sudeep Pushpakom, University of Liverpool)
- Oncology pharmacogenetics (Dr Bill Newman, Central Manchester Hospitals and University of Manchester)
- Case studies in cancer (Dr Fiona Blackhall, Dr Mark Saunders, Christie Hospital, Manchester)
- Health economic implications of personalised medicine (Professor Katherine Payne, University of Manchester)
- Industrial perspective (Dr Colin Spraggs, GlaxoSmithKline)
Early Bird discount has been extended to 9 November.
For full course programme and booking information, see: